From the Department of Ophthalmology (Pasricha, Haq, Chan, Redd, Seitzman, Parikh, Kim, Schallhorn, Ramanathan), School of Medicine (Ahmad), and Francis I. Proctor Foundation (Redd, Seitzman, Schallhorn), University of California San Francisco, San Francisco, California, USA.
Corresponding author: Saras Ramanathan, MD, Department of Ophthalmology, University of California San Francisco, 10 Koret Way, San Francisco, CA 94131. Email: [email protected].
Supported in part by a Research to Prevent Blindness unrestricted grant to the University of California San Francisco, Department of Ophthalmology.
Disclosures: G.D. Seitzman is a consultant for Dompé Pharmaceuticals. J.M. Schallhorn is a consultant for ZEISS and Vanda Pharmaceuticals. The other authors have no financial or proprietary interest in any material or method mentioned.
First author:Neel D. Pasricha, MDDepartment of Ophthalmology, University of California San Francisco, San Francisco, California, USA